01 8WAYLIS THERAP
01 48101209
02 48101209*PED
01 8Blank
01 4Y
02 4Blank
01 42025-09-11
02 42026-03-11
Patent Expiration Date : 2025-09-11
US Patent Number : 8101209
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22012
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-09-11
Patent Expiration Date : 2025-09-11
US Patent Number : 8101209
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22012
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-09-11
Patent Expiration Date : 2025-09-11
US Patent Number : 8101209
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22012
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-09-11
Patent Expiration Date : 2025-09-11
US Patent Number : 8101209
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22012
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-09-11
Patent Expiration Date : 2026-03-11
US Patent Number : 8101209*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 22012
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-03-11
Patent Expiration Date : 2026-03-11
US Patent Number : 8101209*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 22012
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-03-11
Patent Expiration Date : 2026-03-11
US Patent Number : 8101209*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 22012
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-03-11
Patent Expiration Date : 2026-03-11
US Patent Number : 8101209*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 22012
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-03-11
LOOKING FOR A SUPPLIER?
